These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24068669)

  • 1. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development.
    Timblin GA; Schlissel MS
    J Immunol; 2013 Nov; 191(9):4676-87. PubMed ID: 24068669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Mechanism of
    Timblin GA; Xie L; Tjian R; Schlissel MS
    Mol Cell Biol; 2017 Jun; 37(12):. PubMed ID: 28373291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gfi1b negatively regulates Rag expression directly and via the repression of FoxO1.
    Schulz D; Vassen L; Chow KT; McWhirter SM; Amin RH; Möröy T; Schlissel MS
    J Exp Med; 2012 Jan; 209(1):187-99. PubMed ID: 22201127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK5 activates Rag transcription via Foxo1 in developing B cells.
    Chow KT; Timblin GA; McWhirter SM; Schlissel MS
    J Exp Med; 2013 Jul; 210(8):1621-34. PubMed ID: 23878308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAG-Mediated DNA Breaks Attenuate PU.1 Activity in Early B Cells through Activation of a SPIC-BCLAF1 Complex.
    Soodgupta D; White LS; Yang W; Johnston R; Andrews JM; Kohyama M; Murphy KM; Mosammaparast N; Payton JE; Bednarski JJ
    Cell Rep; 2019 Oct; 29(4):829-843.e5. PubMed ID: 31644907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
    Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
    J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.
    Györy I; Boller S; Nechanitzky R; Mandel E; Pott S; Liu E; Grosschedl R
    Genes Dev; 2012 Apr; 26(7):668-82. PubMed ID: 22431510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-7 functionally segregates the pro-B cell stage by regulating transcription of recombination mediators across cell cycle.
    Johnson K; Chaumeil J; Micsinai M; Wang JM; Ramsey LB; Baracho GV; Rickert RC; Strino F; Kluger Y; Farrar MA; Skok JA
    J Immunol; 2012 Jun; 188(12):6084-92. PubMed ID: 22581861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5.
    Roessler S; Györy I; Imhof S; Spivakov M; Williams RR; Busslinger M; Fisher AG; Grosschedl R
    Mol Cell Biol; 2007 Jan; 27(2):579-94. PubMed ID: 17101802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myb Coordinates Survival and the Expression of Genes That Are Critical for the Pre-BCR Checkpoint.
    Fahl SP; Daamen AR; Crittenden RB; Bender TP
    J Immunol; 2018 May; 200(10):3450-3463. PubMed ID: 29654210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factors E2A, FOXO1 and FOXP1 regulate recombination activating gene expression in cancer cells.
    Chen Z; Xiao Y; Zhang J; Li J; Liu Y; Zhao Y; Ma C; Luo J; Qiu Y; Huang G; Korteweg C; Gu J
    PLoS One; 2011; 6(5):e20475. PubMed ID: 21655267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells.
    Lazorchak AS; Liu D; Facchinetti V; Di Lorenzo A; Sessa WC; Schatz DG; Su B
    Mol Cell; 2010 Aug; 39(3):433-43. PubMed ID: 20705244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.
    Ochodnicka-Mackovicova K; Bahjat M; Bloedjes TA; Maas C; de Bruin AM; Bende RJ; van Noesel CJ; Guikema JE
    Blood; 2015 Sep; 126(11):1324-35. PubMed ID: 26153519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells.
    Jin ZX; Kishi H; Wei XC; Matsuda T; Saito S; Muraguchi A
    J Immunol; 2002 Oct; 169(7):3783-92. PubMed ID: 12244173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine pro-B cells require IL-7 and its receptor complex to up-regulate IL-7R alpha, terminal deoxynucleotidyltransferase, and c mu expression.
    Wei C; Zeff R; Goldschneider I
    J Immunol; 2000 Feb; 164(4):1961-70. PubMed ID: 10657646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal regulation of c-myb expression during IL-6-induced differentiation in murine myeloid progenitor M1 cells.
    Zhang J; Han B; Li X; Bies J; Jiang P; Koller RP; Wolff L
    Cell Death Dis; 2016 Sep; 7(9):e2364. PubMed ID: 27607579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive intergenic feedback circuitry, involving EBF1 and FOXO1, orchestrates B-cell fate.
    Mansson R; Welinder E; Åhsberg J; Lin YC; Benner C; Glass CK; Lucas JS; Sigvardsson M; Murre C
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):21028-33. PubMed ID: 23213261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development.
    Amin RH; Schlissel MS
    Nat Immunol; 2008 Jun; 9(6):613-22. PubMed ID: 18469817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.